Alan Thomas, MD
Sleep Medicine · Birmingham, ALNPI 1528066313
Payments from drug & device makers
Across 754 payments — averaging $482.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$185K
- Jazz Pharmaceuticals Inc.$88K
- GSK$42K
- AstraZeneca$23K
- Sanofi US Services Inc.$18K
- Boehringer Ingelheim$1K
- plus $6K from 45 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$363,696 in reported general payments places this provider in the 85th percentile of 28 sleep medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other sleep medicine in Birmingham
- Robert DoekelBirmingham$351K
- William AdamsBirmingham$181K
- Erin OzgunBirmingham$16K
- Melissa JordanBirmingham$2K
- Weddington KelleyBirmingham$940
- Syed NabiBirmingham$457
- Stuart PadoveBirmingham$15
- Michael LedetDaphne$3M
- James RoyHuntsville$823K
- Gordon WarnerCullman$784K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.